HEK293T BRE-Luc/TK Renilla cell line

The cell line stably expresses BMP responsive element (BRE)-Luciferase. The cell line also contains a Renilla reporter driven by the thymidine kinase (TK) promoter to act as an internal control.

Contributors

Inventor Institute
Caroline Hill The Francis Crick Institute
SKU: 156440
Product description: The human embryo kidney cell line HEK293T modified for use as a reporter cell line for bone morphogenetic protein (BMP) signalling. The cell line stably expresses BMP responsive element (BRE)-Luciferase. The cell line also contains a Renilla reporter driven by the thymidine kinase (TK) promoter to act as an internal control. BMP is a transforming growth factor beta (TGF-beta) superfamily member.
Conditional description: Luciferase is expressed in the presence of bone morphogenetic protein (BMP) signalling
Production details: Made by transfecting the human embryo kidney cell line HEK293T with BRE-Luciferase plasmid, TK Renilla plasmid and pRetroSuper for puromycin resistance.
Parental cell line: HEK293T cell line
Cat. #: 156440
Tool sub type: Continuous
Unit size: 1×10^6 cells / vial
Research Fields: Cancer; Cell signaling and signal transduction; Developmental biology
Organism: Human
Tissue: Kidney
Model: Reporter
Format: Frozen
Storage conditions: Liquid Nitrogen
Shipping conditions: Dry ice
Growth medium: Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal calf serum (FCS)
Recommended controls: HEK293 parental line
Mycoplasma free: Yes
Biosafety level: 1
References:

Gori et al. 2021. eLife 8,10:e63545. PMID: 33416497

Related Tools for Cell lines

Cat. # Tool Name
156439 MDA-MB-231 BRE-Luc/TK Renilla cell line Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.